{"id":"W3042003151","doi":"10.1111/bjd.19393","title":"Long‐term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3‐year results from two randomized phase III trials (CIMPASI‐1 and CIMPASI‐2)","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Psoriasis; Plaque psoriasis; Term (time); Randomized controlled trial; Internal medicine; Dermatology; Adalimumab; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003685036,0.0002959975,0.002880387,0.0001205969,0.0001513958,0.00002567299,0.0003068643,0.0002898196,0.0001266303],"category_scores_gemma":[0.001360635,0.000212758,0.0009327285,0.0001116279,0.0004366082,0.00009683779,0.0000350678,0.0001593763,0.000006057907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002862887,"about_ca_system_score_gemma":0.0001865952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002894659,"about_ca_topic_score_gemma":0.00006885928,"domain_scores_codex":[0.9955188,0.00150914,0.002264721,0.0002964166,0.00008049607,0.0003304396],"domain_scores_gemma":[0.9904125,0.007037267,0.002013717,0.0002248981,0.0002233713,0.00008819018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7717557,0.00159686,0.0006742479,0.00005328403,0.01006029,0.001296896,0.004125609,0.0000059081,0.01084188,0.0001141639,0.002591483,0.1968837],"study_design_scores_gemma":[0.9056902,0.001582867,0.001382661,0.0001763972,0.004728491,0.0135333,0.0003674463,0.00001563886,0.07033874,0.0001293699,0.001840886,0.0002140426],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9453619,0.04764993,0.0008687321,0.00255863,0.000837663,0.001327384,0.00134511,0.00001579934,0.00003484754],"genre_scores_gemma":[0.9830454,0.0161204,0.0002696133,0.00003826613,0.0002455265,0.00004386565,0.0001795652,0.00002493676,0.00003245212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1966696,"threshold_uncertainty_score":0.8676019,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04312098484127033,"score_gpt":0.3067506831711608,"score_spread":0.2636296983298905,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}